The recent approval of the Pfizer-BioNTech coronavirus vaccine means more than just enticing some previously hesitant people to roll up their sleeves. The upgrade from an emergency use authorization ...

Add Yahoo as a preferred source to see more of our stories on Google. Pfizer and BioNTech's COVID-19 vaccine got full FDA approval on Monday. Its name, Comirnaty, is a mash-up of community, immunity, ...

Well, it’s official. The U.S. Food and Drug Administration (FDA) has now officially approved the first Covid-19 vaccine for people 16 years and older, as Jemima McEvoy reported for Forbes. People have ...

Despite a plan to jack up the price of Comirnaty to between $110 and $130 per dose when the United States goes to a commercial model this year for COVID-19 vaccines, Pfizer expects revenue from the ...

Referring to COVID-19 vaccines by their brand names, an article headline misleads about their availability. “Few, If Any, Doses of Spikevax or Comirnaty Available in United States, Despite FDA ...

Quick ReadPFE's 7.27% yield looks safe on a 53% adjusted payout ratio, but free cash flow fell short of dividends paid in ...

The Food and Drug Administration gave full approval to the Pfizer-BioNTech coronavirus vaccine on Monday, making it one of the most important days in the history of the pharmaceutical company. But, ...